Institute of Orthopedic Diseases and Department of Bone and Joint Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Department of Orthopedic Surgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Pharm Biol. 2020 Dec;58(1):297-305. doi: 10.1080/13880209.2020.1743325.
L. (Rosaceae), a famous traditional Chinese medicine. It was recently reported that its polysaccharide could facilitate collagen production. We investigated the mechanism by which polysaccharide (SOWPa) and/or platelet-rich plasma (PRP) promote regenerative potential of anterior cruciate ligament (ACL) . ACL fibroblasts were treated with SOWPa (25 and 100 mg/kg), PRP, PRP + SOWPa (25 and 100 mg/kg) or vehicle alone for 24, 48, or 72 h. Cell viability, migration ability and apoptosis were evaluated by MTT, transwell and flow cytometry, respectively. Western blot analysis was performed to assess associated protein expression. PRP, SOWPa (100 mg/kg) or PRP + SOWPa (100 mg/kg) treatment for 72 h significantly improved the cell viability of ACL fibroblasts from 100 ± 7.5% (control) to 156.85 ± 12.82%, 188.08 ± 15.92%, and 223.67 ± 18.82%, respectively, which was evidenced by individual decreased apoptosis rate from 31.26 ± 2.35% (control) to 20.80 ± 1.89%, 18.01 ± 1.55% and 9.33 ± 0.78%. Furthermore, the motility of ACL fibroblasts was significantly improved with increased migrated cell number per field from 5 for control to 26 for PRP, 36 for SOWPa and 44 for PRP + SOWPa, respectively. Moreover, the protein expression of differentiation markers (RUNX2, ALP, BMP2 and Col I) and TLR-4 and phosphorylated p65 (p-p65) was inhibited by the above treatment. Data suggested that the addition of SOWPa to PRP increased the regenerative ability of ACL fibroblasts by blocking the TLR-4/NF-κB pathway.
白芍(蔷薇科),一种著名的中药。最近有报道称,其多糖可促进胶原蛋白的产生。我们研究了多糖(SOWPa)和/或富含血小板的血浆(PRP)促进前交叉韧带(ACL)再生潜力的机制。ACL 成纤维细胞用 SOWPa(25 和 100mg/kg)、PRP、PRP+SOWPa(25 和 100mg/kg)或单独载体处理 24、48 或 72 小时。通过 MTT、transwell 和流式细胞术分别评估细胞活力、迁移能力和细胞凋亡。通过 Western blot 分析评估相关蛋白表达。PRP、SOWPa(100mg/kg)或 PRP+SOWPa(100mg/kg)处理 72 小时可显著提高 ACL 成纤维细胞的细胞活力,从对照的 100±7.5%提高到 156.85±12.82%、188.08±15.92%和 223.67±18.82%,这表现为凋亡率从对照的 31.26±2.35%个体下降到 20.80±1.89%、18.01±1.55%和 9.33±0.78%。此外,ACL 成纤维细胞的迁移能力显著提高,每个视野迁移的细胞数从对照的 5 个增加到 PRP 的 26 个、SOWPa 的 36 个和 PRP+SOWPa 的 44 个。此外,上述治疗还抑制了分化标志物(RUNX2、ALP、BMP2 和 Col I)和 TLR-4 及磷酸化 p65(p-p65)的蛋白表达。数据表明,SOWPa 与 PRP 联合使用通过阻断 TLR-4/NF-κB 通路增加了 ACL 成纤维细胞的再生能力。